Two Reflections about Amadori Products: Biomarkers or Therapeutic Targets for Coronary Artery Disease?

Publisher： Karger

E-ISSN： 1421-9751|123|2|81-83

ISSN： 0008-6312

Source： Cardiology, Vol.123, Iss.2, 2012-09, pp. : 81-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Biomarkers in acute coronary artery disease

By Freynhofer Matthias K.   Tajsić Miloš   Wojta Johann   Huber Kurt  

Wiener Medizinische Wochenschrift, Vol. 162, Iss. 21-22, 2012-11 ,pp. : 489-498

Springer Publishing Company

Access to resources Recommend Favorite

Cangrelor: an emerging therapeutic option for patients with coronary artery disease

By Kubica Jacek   Kozinski Marek   Navarese Eliano Pio   Tantry Udaya   Kubica Aldona   Siller-Matula Jolanta Maria   Jeong Young-Hoon   Fabiszak Tomasz   Andruszkiewicz Anna   Gurbel Paul Alfred  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 813-828

Informa Healthcare

Access to resources Recommend Favorite

CORONARY ARTERY DISEASE IN THE AGED*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 1, Iss. 3, 1953-03 ,pp. : 166-169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia

By  

Cardiology, Vol. 118, Iss. 3, 2011-06 ,pp. : 187-194

Karger

Access to resources Recommend Favorite

Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin

By Zhong Yucheng  

Upsala Journal of Medical Sciences, Vol. 117, Iss. 4, 2012-11 ,pp. : 390-398

Informa Healthcare

Access to resources Recommend Favorite